Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Anandamide: a candidate neurotransmitter heads for the big leagues

Nature Neuroscience volume 2, pages 303–304 (1999)Cite this article

Abstract

Activation of dopamine receptors triggers release of anandamide, an endogenous cannabinoid, in vivo, leading to inhibition of dopamine-mediated locomotor behavior.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Possible pathways by which D2 dopamine receptors could trigger anandamide release.

References

  1. Felder, C. C. & Glass, M. Annu. Rev. Pharmacol. Toxicol. 38, 179–200 (1998).

    Article  CAS  Google Scholar 

  2. Howlett, A. C. & Fleming, R. M. Mol. Pharmacol. 26, 532–538 (1984).

    CAS  PubMed  Google Scholar 

  3. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C. & Bonner, T. I. Nature 346, 561–564 (1990).

    Article  CAS  Google Scholar 

  4. Kosterlitz, H. W. & McKnight, A. T. Adv. Intern. Med. 26, 1–36 (1980).

    CAS  PubMed  Google Scholar 

  5. Giuffrida, A. et al. Nat. Neurosci. 2, 358– 363 (1999).

    Article  CAS  Google Scholar 

  6. Devane, W. A. et al. Science 258, 1946– 1949 (1992).

    Article  CAS  Google Scholar 

  7. Terranova, J. P. et al. Psychopharmacology 126, 165– 172 (1996).

    Article  CAS  Google Scholar 

  8. Navarro, M. et al. Neuroreport 8, 491– 496 (1997).

    Article  CAS  Google Scholar 

  9. Glass, M. & Felder, C. C. J. Neurosci. 17, 5327–5333 (1997).

    Article  CAS  Google Scholar 

  10. Van Ree, J. N., Slangen, J. F. & De Wied, D. J. Pharmacol. Exp. Ther. 204, 547–557 (1978).

    CAS  PubMed  Google Scholar 

  11. Takahashi, R. N. & Singer, G. Pharmacol. Biochem. Behav. 11, 737–740 (1979).

    Article  CAS  Google Scholar 

  12. Koob, G. F. & LeMoal, M. Science 278, 52–58 (1997).

    Article  CAS  Google Scholar 

  13. Glass, M., Faull, R. L. & Dragunow, M. Neuroscience 56, 523– 527 (1993).

    Article  CAS  Google Scholar 

  14. Richfield, E. K. & Herkenham, M. Ann. Neurol. 36, 577–584 (1994).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Molecular Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, 34 Park St., New Haven, 06508, Connecticut, USA

    David W. Self

Authors
  1. David W. Self
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Self, D. Anandamide: a candidate neurotransmitter heads for the big leagues. Nat Neurosci 2, 303–304 (1999). https://doi.org/10.1038/7210

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/7210

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing